Use of pemetrexed as first line treatment of advanced non-small cell lung cancer: The Czech Republic experience with the treatment of 237 patients (pts)

• Authors: SKŘIČKOVÁ Jana; BORTLÍČEK Zbyněk; HEJDUK Karel; PEŠEK M.; KOLEK V.; KOUBKOVÁ L.; TOMÍŠKOVÁ Marcela; ROUBEC J.; ZATLOUKAL P.; SALAJKA F.
• Year of publication: 2012
• Type: Conference abstract
• MU Faculty or unit: Faculty of Medicine

Attached files

• Skrickovlung_cancer_006.pdf

• Description: The Czech Republic has had an opportunity to use pemetrexed for 1st line treatment of advanced NSCLC from the year 2008. The purpose of this trial was to evaluate the activity and feasibility of pemetrexed in 1st line treatment NSCLC patients.